Impacts of receiving Alzheimer's disease genetic risk information among Latinos in northern Manhattan
曼哈顿北部拉丁裔接受阿尔茨海默病遗传风险信息的影响
基本信息
- 批准号:10538577
- 负责人:
- 金额:$ 265.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-15 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcculturationAddressAdultAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAnxietyApolipoprotein EBehavioralBelief SystemCaribbean HispanicCaucasiansCharacteristicsCognitionCommunitiesCoping SkillsCounselingDataDisclosureDiseaseDistressDominicanEducationEnrollmentEthnic OriginEthnic PopulationEuropean ancestryEvaluationEventFamilyFamily history ofGeneral PopulationGeneticGenetic Predisposition to DiseaseGenetic RiskGenetic StatusGenotypeHealth behaviorHeightHomozygoteIncidenceInfluentialsInterventionInterviewInvestigationLate Onset Alzheimer DiseaseLatinoLatino PopulationLearningMasksMeasuresMemoryMental DepressionMethodologyMethodsModelingModificationOutcomeParticipantPatient Self-ReportPatternPersonsPopulationPrevention trialPsychosocial Assessment and CareQualitative ResearchQuestionnairesRandomizedRecording of previous eventsResearchRiskRisk AssessmentRisk EstimateRisk MarkerRunningSamplingSourceStress and CopingStudy of LatinosSubgroupSurveysSusceptibility GeneTelephoneTestingTimeTreatment/Psychosocial EffectsWashingtonWorkadverse outcomeanxiety symptomsapolipoprotein E-4behavior changecontextual factorscopingcultural valuesdepressive symptomsdesignemotion regulationethnic minority populationexperiencegenetic informationgenetic predictorsgenetic testinghigh riskimprovedinterestlifetime riskperformance testspresymptomatic testingprimary endpointpsychosocialresponsesecondary endpointsocial stigmastandardize measure
项目摘要
PROJECT SUMMARY
This study will assess the psychosocial and behavioral impacts of receiving a risk assessment for late-
onset Alzheimer's disease (LOAD) incorporating APOE genotypes among Latinos in northern Manhattan. We
will conduct a longitudinal, community-based study with a mixed methods design and diverse, nuanced, and
sensitive assessments of impact. Participants will be randomized to learn about their lifetime risk of LOAD
based either on (a) ethnicity and family history alone (genotype nondisclosure group), or (b) the same factors
plus APOE genotype (genotype disclosure group). Impacts will be evaluated at 6 weeks, 9 months, and 18
months after risk assessment.
In the quantitative study component, we will assess psychosocial outcomes, memory test performance,
and health-related behaviors. The primary endpoints are a significant difference between the genotype
disclosure and nondisclosure groups' scores on: (1) the Impact of Genetic Testing in AD scale, (2) the Impact
of Events Scale, (3) the Metamemory in Adulthood Questionnaire, and (4) the Brief Test of Adult Cognition by
Telephone. The secondary endpoints are significant differences in symptoms of depression or anxiety, health-
related behavior changes, perceived threat of AD, and recall and understanding of risk information. We will
also investigate factors that underlie variability in response and explore the patterns of longitudinal response to
the receipt of genetic information.
In the qualitative study component, we will use a stress and coping theoretical framework to investigate the
lived experience of receiving personal AD risk information. This will include examination, at each time point, of
the ways in which participants understand and appraise AD risk information, how this is influenced by their lay
belief systems about genetics and AD illness representations, and what coping strategies they enact to
contend with their risk, its perceived implications, and the adaptive challenges it may pose. We will also assess
how coping strategies change over time and the contextual factors and conditions associated with those
changes, including Latino cultural values and norms; and how different coping strategies may enhance or
impede adjustment to AD risk information.
The results will help identify persons at high risk for adverse consequences of APOE testing and inform
interventions to assist them to cope effectively. The information will be important for tailoring genetic education
or counseling interventions to Latinos.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUTH OTTMAN其他文献
RUTH OTTMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUTH OTTMAN', 18)}}的其他基金
Impacts of receiving Alzheimer's disease genetic risk information among Latinos in northern Manhattan
曼哈顿北部拉丁裔接受阿尔茨海默病遗传风险信息的影响
- 批准号:
9884404 - 财政年份:2020
- 资助金额:
$ 265.64万 - 项目类别:
Impacts of receiving Alzheimer's disease genetic risk information among Latinos in northern Manhattan
曼哈顿北部拉丁裔接受阿尔茨海默病遗传风险信息的影响
- 批准号:
10317041 - 财政年份:2020
- 资助金额:
$ 265.64万 - 项目类别:
Validation of a Standardized Diagnostic Interview for Epilepsy
癫痫标准化诊断访谈的验证
- 批准号:
7787638 - 财政年份:2009
- 资助金额:
$ 265.64万 - 项目类别:
Validation of a Standardized Diagnostic Interview for Epilepsy
癫痫标准化诊断访谈的验证
- 批准号:
7921366 - 财政年份:2009
- 资助金额:
$ 265.64万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 265.64万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 265.64万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 265.64万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 265.64万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 265.64万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 265.64万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 265.64万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 265.64万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 265.64万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 265.64万 - 项目类别:
Research Grant